FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W165074277> ?p ?o ?g. }

• W165074277 abstract "P : Major depression (MD) is one of the most costly diseases in the world (Wasserman, 2006). Untreated affective disorders tend to be chronic and also life-threatening, since depression commonly preceeds suicide. In the clinic, these patients must be assesed for their risk of suicide, as it is estimated to be the cause of death in 10-15% of individuals with MD (Wasserman, 2006). To expand the possibilities of intervention and therapy of suicidality, particularly in connection to the treatment of MD, its neurobiological causality is being explored (Mann, 2003; Wasserman, 2001). In a stress-vulnerability model, genetic set-up, as well as environmental exposure to psychological stress, contributes to a person's predisposition for suicidality, as well as to MD (Hasler et al., 2004; Mann, 2003; Wasserman, 2001). The main neurochemical findings on suicidality have suggested alterations in neurosystems which are usually implicated in MD; a lowered serotonergic (5HT) activity, depletion of the noradrenergic (NA) system and dysregulation of the hypothalamic-pituitary-adrenal (HPA) axis. Whereas the genes of e.g. the 5HT system and of the key NA-biosynthesis enzyme, tyrosine hydroxylase, have been studied extensively in this context (Bondy et al., 2006; Rujescu et al., 2007), the genes in the HPA axis have only begun to be investigated recently. An over-active HPA axis is also the most consistent neurobiological indicator of MD (Bale, 2005; Hasler et al., 2004; Nemeroff & Vale, 2005; Roy et al., 1987; Swaab et al., 2005). This is true also true for some suicidal individuals, as an overactive HPA axis, particularly in connection to depression, is often preceeding suicide (Coryell & Schlesser, 2001; Young, 2005). The HPA-activity is primarilly attributed to the action of corticotropin releasing hormone (CRH) and by altered feedback regulation of the axis through the glucocorticoid and mineralocorticoid receptors, which is manifested as hypercortisolemia and a failure to supress cortisol. CRH alterations have also been observed in extrahypothalamic brain regions, e.g. the frontal cortex, limbic regions and cerebro spinal fluid (CSF). CRH acts as the key mediator of behavioral, cognitive, autonomic, neuroendocrine and immunologic responses to aversive stimuli (emotional and physical stress or inflammation), acting mainly through the CRH receptor 1 (CRHR1). In the HPA axis, CRH binds to CRHR1s in the anterior pituitary. This results in production of proopiomelanocortin (POMC)-derived peptides, such as adrenocorticotropic hormone (ACTH), which in turn stimulate the adrenal gland to secrete glucocorticoids (but also mineralocorticoids and androgens). The steroid act on GRs and MRs in many tissues, including the brain, particularly parts of the brain stem and limbic regions. A functional response in the feedback regulation, occuring through the balanced activation of GRs and MRs, as well as by downregulating the expression of CRHR1 in the pituitary (Aguilera et al., 2004), is crucial for returning to a normal state. A chronic state of CRH-mediated activity, e.g. due to adverse environmental stress or defective coping with low levels of stress, may result in disruption of the HPA axis feedback with consequences for e.g. the innervating limbic functions. Monoaminergic neurotransmission is affected, by e.g. suppression of the 5-HT receptor 1a in the dorsal raphe nuclei (Meijer & de Kloet, 1998) or by affecting NA in locus coeruleus (LC). Parallel effects of high levels of CRH (by action through its receptors), includes the increased release of pro-inflammatory cytokines by immune cells, activating the indoleamine 2,3-dioxygenase (IDO) pathway, with subsequent consequences of tryptophan(5HT-) depletion and neurotoxicity, as well as glutamatergic hyperfunction (Leonard, 2005; Muller & Schwarz, 2007). Thus, disturbances in HPA axis responsiveness connected to CRH, are relevant in MD, as well as in suicidality. The effects of CRH dysregulation are primarilly mediated through CRHR1. Consequently, antagonists active against CRHR1 are being developed as a novel type of antidepressants (Nielsen, 2006). From a pharmacogenomic perspective, it is of importance to have access to the level of individual variation in this gene in context to its functionality, which can be needed for evaluation of treatment efficacy as well as being used in diagnostic tools. Knowledge about dysfunctional CRHR1 variants may also bring about new, highly specific treatment possiblities with inhibitory RNAs (Sah, 2006). Surprisingly little is known about influence of genetic variations in the CRHR1 gene in the context of stress and depression, since only a few such studies have been reported up to date (Licinio et al., 2004; Liu et al., 2007; Liu et al., 2006; Papiol et al., 2007; Wasserman et al., 2007). In fact, our group has been the first to study the genetic variation in the CRHR1 gene in connection to depression and stress among suicidal individuals (Wasserman et al., 2007)." @default.
• W165074277 created "2016-06-24" @default.
• W165074277 creator A5054716465 @default.
• W165074277 creator A5066885617 @default.
• W165074277 creator A5073947215 @default.
• W165074277 date "2015-04-29" @default.
• W165074277 modified "2023-09-26" @default.
• W165074277 title "Relation of genes regulating the HPA-axis to major depression and suicidality: novel findings" @default.
• W165074277 cites W1961990310 @default.
• W165074277 cites W1978476465 @default.
• W165074277 cites W1982986505 @default.
• W165074277 cites W1993512624 @default.
• W165074277 cites W1999682854 @default.
• W165074277 cites W2002250647 @default.
• W165074277 cites W2011561905 @default.
• W165074277 cites W2015481673 @default.
• W165074277 cites W2016364360 @default.
• W165074277 cites W2039531403 @default.
• W165074277 cites W2041139309 @default.
• W165074277 cites W2042537475 @default.
• W165074277 cites W2051080797 @default.
• W165074277 cites W2064302385 @default.
• W165074277 cites W2068500609 @default.
• W165074277 cites W2088318598 @default.
• W165074277 cites W2095350413 @default.
• W165074277 cites W2095577066 @default.
• W165074277 cites W2115940067 @default.
• W165074277 cites W2125441992 @default.
• W165074277 cites W2128562941 @default.
• W165074277 cites W2129584474 @default.
• W165074277 cites W2137625559 @default.
• W165074277 cites W2170226754 @default.
• W165074277 cites W2345802250 @default.
• W165074277 cites W3209333095 @default.
• W165074277 cites W567453609 @default.
• W165074277 doi "https://doi.org/10.5617/suicidologi.1787" @default.
• W165074277 hasPublicationYear "2015" @default.
• W165074277 type Work @default.
• W165074277 sameAs 165074277 @default.
• W165074277 citedByCount "0" @default.
• W165074277 crossrefType "journal-article" @default.
• W165074277 hasAuthorship W165074277A5054716465 @default.
• W165074277 hasAuthorship W165074277A5066885617 @default.
• W165074277 hasAuthorship W165074277A5073947215 @default.
• W165074277 hasBestOaLocation W1650742771 @default.
• W165074277 hasConcept C118552586 @default.
• W165074277 hasConcept C126322002 @default.
• W165074277 hasConcept C134018914 @default.
• W165074277 hasConcept C139719470 @default.
• W165074277 hasConcept C151730666 @default.
• W165074277 hasConcept C15744967 @default.
• W165074277 hasConcept C162324750 @default.
• W165074277 hasConcept C169760540 @default.
• W165074277 hasConcept C170493617 @default.
• W165074277 hasConcept C25876315 @default.
• W165074277 hasConcept C2775864247 @default.
• W165074277 hasConcept C2776867660 @default.
• W165074277 hasConcept C2779343474 @default.
• W165074277 hasConcept C37000724 @default.
• W165074277 hasConcept C71924100 @default.
• W165074277 hasConcept C86803240 @default.
• W165074277 hasConceptScore W165074277C118552586 @default.
• W165074277 hasConceptScore W165074277C126322002 @default.
• W165074277 hasConceptScore W165074277C134018914 @default.
• W165074277 hasConceptScore W165074277C139719470 @default.
• W165074277 hasConceptScore W165074277C151730666 @default.
• W165074277 hasConceptScore W165074277C15744967 @default.
• W165074277 hasConceptScore W165074277C162324750 @default.
• W165074277 hasConceptScore W165074277C169760540 @default.
• W165074277 hasConceptScore W165074277C170493617 @default.
• W165074277 hasConceptScore W165074277C25876315 @default.
• W165074277 hasConceptScore W165074277C2775864247 @default.
• W165074277 hasConceptScore W165074277C2776867660 @default.
• W165074277 hasConceptScore W165074277C2779343474 @default.
• W165074277 hasConceptScore W165074277C37000724 @default.
• W165074277 hasConceptScore W165074277C71924100 @default.
• W165074277 hasConceptScore W165074277C86803240 @default.
• W165074277 hasIssue "3" @default.
• W165074277 hasLocation W1650742771 @default.
• W165074277 hasOpenAccess W165074277 @default.
• W165074277 hasPrimaryLocation W1650742771 @default.
• W165074277 hasRelatedWork W1483678245 @default.
• W165074277 hasRelatedWork W195891757 @default.
• W165074277 hasRelatedWork W1985170550 @default.
• W165074277 hasRelatedWork W2011424447 @default.
• W165074277 hasRelatedWork W2039628081 @default.
• W165074277 hasRelatedWork W2063946921 @default.
• W165074277 hasRelatedWork W2064014994 @default.
• W165074277 hasRelatedWork W2075424733 @default.
• W165074277 hasRelatedWork W2087224713 @default.
• W165074277 hasRelatedWork W2093472917 @default.
• W165074277 hasRelatedWork W2127637048 @default.
• W165074277 hasRelatedWork W2134915078 @default.
• W165074277 hasRelatedWork W2142146658 @default.
• W165074277 hasRelatedWork W2270584696 @default.
• W165074277 hasRelatedWork W2492685920 @default.
• W165074277 hasRelatedWork W2777373311 @default.
• W165074277 hasRelatedWork W3004077973 @default.
• W165074277 hasRelatedWork W3117676703 @default.
• W165074277 hasRelatedWork W3119556828 @default.

• next